urology lecture
TRANSCRIPT
![Page 1: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/1.jpg)
UROLOGYUROLOGY
![Page 2: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/2.jpg)
PHYSICAL EXAMINATION PHYSICAL EXAMINATION OF THE GENITOURINARY OF THE GENITOURINARY
TRACTTRACT
![Page 3: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/3.jpg)
Unusual findings on Unusual findings on general examinationgeneral examination
1.1. Gynecomastia:Gynecomastia:
a. estrogen treatment for a. estrogen treatment for prostateprostate
cancercancer
b. testicular cancerb. testicular cancer
c. adrenocortical hyperplasiac. adrenocortical hyperplasia
d. disease of the liverd. disease of the liver
![Page 4: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/4.jpg)
Physical examinationPhysical examination
2. Hemihypertrophy:2. Hemihypertrophy:
a. Wilm’s tumora. Wilm’s tumor
b. adrenal tumorsb. adrenal tumors
c. Neuroblastomac. Neuroblastoma
3. Clues to renal anomalies- 3. Clues to renal anomalies-
a. lateral displacement of the a. lateral displacement of the nipples:nipples:
bilateral renal hypoplasiabilateral renal hypoplasia
![Page 5: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/5.jpg)
Physical ExaminationPhysical Examination
4. Others: endocrinologic changes:4. Others: endocrinologic changes:
a. hypertrophy of the external a. hypertrophy of the external
genitaliagenitalia
b. hirsutismb. hirsutism
c. hypertensionc. hypertension
![Page 6: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/6.jpg)
Physical examinationPhysical examination
Examination of the kidneys;Examination of the kidneys;
1. Inspection: masses/fullness1. Inspection: masses/fullness
-tumors-tumors
-infections-infections
2. Palpation: 2. Palpation:
-technique-technique
-finding: mass ; -finding: mass ; tendernesstenderness
![Page 7: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/7.jpg)
Physical ExaminationPhysical Examination
3.percussion: -hydronephrosis3.percussion: -hydronephrosis
-tumors-tumors
-trauma-trauma
4. Auscultation: systolic bruit-4. Auscultation: systolic bruit-
aneurysmsaneurysms
![Page 8: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/8.jpg)
Renal vs. Radicular painRenal vs. Radicular pain
Radicular pain: costovertebral and Radicular pain: costovertebral and subcostal subcostal
areas spreads along the areas spreads along the coursecourse
of the ureterof the ureter
Causes:Causes:
- poor posture- poor posture
- arthritic changes- arthritic changes
- intervertebral disc disease- intervertebral disc disease
![Page 9: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/9.jpg)
Physical ExaminationPhysical Examination
The BladderThe Bladder
- in adults, at least 150 ml to be - in adults, at least 150 ml to be
percussiblepercussible
- the best way to detect if full-- the best way to detect if full-percussionpercussion
![Page 10: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/10.jpg)
Male External GenitaliaMale External Genitalia
PenisPenis
1. Inspection: if uncircumcised, 1. Inspection: if uncircumcised, foreskinforeskin
should be retractedshould be retracted
a. tumors, balanitisa. tumors, balanitis
![Page 11: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/11.jpg)
Poor bladder stream:Poor bladder stream:
-BPH or Prostate CA-BPH or Prostate CA
-posterior urethral valves in -posterior urethral valves in childrenchildren
-strictures-strictures
![Page 12: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/12.jpg)
The meatus: bloody spotting- meatal The meatus: bloody spotting- meatal stenosis,stenosis,
tumorstumors
-hypospadias-hypospadias
-epispadias-epispadias
2. Palpation: Peyronie’s disease, 2. Palpation: Peyronie’s disease, strictures,strictures,
dischargesdischarges
![Page 13: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/13.jpg)
Scrotum: - inflammatory changesScrotum: - inflammatory changes
- elephantiasis- elephantiasis
Testis:- a hard area should be regarded as Testis:- a hard area should be regarded as
malignant until proven otherwisemalignant until proven otherwise
Transillumination: hydrocele vs. solid Transillumination: hydrocele vs. solid massmass
Absent testis: cryptorchidism vs.retractile Absent testis: cryptorchidism vs.retractile
testistestis
![Page 14: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/14.jpg)
Epididymis: induration- usually infectiousEpididymis: induration- usually infectious - malignant tumors - malignant tumors
areare exceedingly rareexceedingly rare
Spermatic cord: - swelling:cystic(hydrocele Spermatic cord: - swelling:cystic(hydrocele or hernia) vs, solid(tumors, lipoma)or hernia) vs, solid(tumors, lipoma)
-varicocele:dilated veins of -varicocele:dilated veins of the pampiniform plexus (“bag of worms”) the pampiniform plexus (“bag of worms”)
![Page 15: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/15.jpg)
Vas DeferensVas Deferens
- thickening: chronic - thickening: chronic inflammationinflammation
- “beading” : TB- “beading” : TB
- absent (congenital)- absent (congenital)
![Page 16: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/16.jpg)
Vaginal ExaminationVaginal Examination
-newborns and children: vaginal opening -newborns and children: vaginal opening
should be inspected for ashould be inspected for a
single opening(commonsingle opening(common
urogenital sinus), labial urogenital sinus), labial
fusion, split/hypertrophiedfusion, split/hypertrophied
clitorisclitoris
![Page 17: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/17.jpg)
-urinary meatus:-urinary meatus:
- urethra caruncle: reddened, - urethra caruncle: reddened, tender, tender,
friable, lesionfriable, lesion
- urethral discharges: smears - urethral discharges: smears should beshould be
mademade
![Page 18: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/18.jpg)
Rectal ExaminationRectal Examination
- laxity or spasticity: neurogenic - laxity or spasticity: neurogenic diseasedisease
- digital prostate exam- digital prostate exam
- rectal stenosis- rectal stenosis
- hemorrhoids, rectal fistulas- hemorrhoids, rectal fistulas
![Page 19: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/19.jpg)
Lymph nodesLymph nodes
- in inflammatory lesions of the penis - in inflammatory lesions of the penis and and
scrotum (males) and vulva (females),scrotum (males) and vulva (females),
the inguinal and subinguinal LN’s may the inguinal and subinguinal LN’s may bebe
involvedinvolved
- malignant tumors of the penis, glans, - malignant tumors of the penis, glans, scrotalscrotal
skin, and distal urethra in womanskin, and distal urethra in woman
![Page 20: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/20.jpg)
Neurologic ExamNeurologic Exam
- Bladder and urethral sphincters: S2 - Bladder and urethral sphincters: S2 – S4– S4
- anal sphincter tone- anal sphincter tone
- sensation of perianal skin- sensation of perianal skin
- eliciting Achilles tendon and - eliciting Achilles tendon and
bulbocavernous reflexbulbocavernous reflex
![Page 21: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/21.jpg)
SYMPTOMS OF SYMPTOMS OF DISORDERS OF THE GU DISORDERS OF THE GU
TRACTTRACT
![Page 22: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/22.jpg)
Symptoms of Disorders Symptoms of Disorders of the Genitourinary of the Genitourinary
TractTractSystemic manifestationsSystemic manifestations
- fever: e.g. acute pyelonephritis- fever: e.g. acute pyelonephritis
- weight loss: e.g. malignancy- weight loss: e.g. malignancy
- failure to thrive (children)e.g. - failure to thrive (children)e.g. chronicchronic
obstruction or UTI, or bothobstruction or UTI, or both
- general malaise: e.g. tumors, - general malaise: e.g. tumors, chronic chronic
pyelonephritis, renal failurepyelonephritis, renal failure
![Page 23: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/23.jpg)
Local and referred painLocal and referred pain
Local pain: felt in or near an involved organ, Local pain: felt in or near an involved organ,
e.g. diseased kidney(T10-12,l1)-e.g. diseased kidney(T10-12,l1)-
felt in the CVA and flankfelt in the CVA and flank
Referred pain(more common): originates in aReferred pain(more common): originates in a
in a disease organ but is felt at in a disease organ but is felt at
some distance from that organ e.g.some distance from that organ e.g.
ureteral colic, acute cystitis ureteral colic, acute cystitis
![Page 24: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/24.jpg)
Specific causes of painSpecific causes of pain
Kidney(Renal pain): dull and constant ache Kidney(Renal pain): dull and constant ache
in the CVA just lateral toin the CVA just lateral to
sacrospinalis muscle and sacrospinalis muscle and
just below the 12just below the 12thth rib e.g rib e.g
acute pyelonephritisacute pyelonephritis
Pseudorenal pain ( Radiculitis)Pseudorenal pain ( Radiculitis)
![Page 25: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/25.jpg)
Ureteral pain (ureteral colic, renal colic): backUreteral pain (ureteral colic, renal colic): back pain from renal capsularpain from renal capsular distention combined with severe distention combined with severe colicky pain that radiates from colicky pain that radiates from the costovertebral angle down the costovertebral angle down towards the lower anterior towards the lower anterior abdominal quadrant, along the abdominal quadrant, along the
coursecourse of the ureterof the ureter
![Page 26: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/26.jpg)
Vesical pain: overdistended bladder, Vesical pain: overdistended bladder, cystitis, cystitis,
bladder TB, schistomiasisbladder TB, schistomiasis
Prostate pain: vague discomfort of Prostate pain: vague discomfort of fullness infullness in
the perineal or rectal areathe perineal or rectal area
(S2-S4)(S2-S4)
![Page 27: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/27.jpg)
Testicular pain: trauma infection, or torsion Testicular pain: trauma infection, or torsion ––
very severe, felt locally andvery severe, felt locally and
there may be radiation to there may be radiation to the the
lower abdomen.lower abdomen.
Epididymal pain: in acute epididymitis Epididymal pain: in acute epididymitis
![Page 28: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/28.jpg)
Back and Leg pain: Back and Leg pain:
suggest metastases to the suggest metastases to the pelvicpelvic
bones (e.g. prostate bones (e.g. prostate cancer)cancer)
![Page 29: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/29.jpg)
Gastrointestinal Gastrointestinal Symptoms of Urologic Symptoms of Urologic
DiseaseDisease
Ex. acute pyelonephritis, ureteral Ex. acute pyelonephritis, ureteral stonestone
Causes:Causes:
1. Renointestinal Reflexes1. Renointestinal Reflexes
2. Organ relationship2. Organ relationship
3. Peritoneal irritation3. Peritoneal irritation
![Page 30: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/30.jpg)
Lower Urinary Tract Lower Urinary Tract SymptomsSymptoms
1. Urgency1. Urgency
2. Frequency2. Frequency
3. Nocturia3. Nocturia
4. Hesitancy4. Hesitancy
5. Intermittency5. Intermittency
6. Sensation of incomplete vioding6. Sensation of incomplete vioding
7. Decrease in the caliber and flow of 7. Decrease in the caliber and flow of thethe
urinary streamurinary stream
![Page 31: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/31.jpg)
IncontinenceIncontinence
1. True (total) incontinence1. True (total) incontinence
2. Stress incontinence2. Stress incontinence
3. Paradoxic incontinence3. Paradoxic incontinence
4. Urge incontinence4. Urge incontinence
![Page 32: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/32.jpg)
Oliguria and AnuriaOliguria and Anuria
PneumaturiaPneumaturia
Cloudy urineCloudy urine
![Page 33: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/33.jpg)
RADIOLOGY OF THE RADIOLOGY OF THE URINARY TRACTURINARY TRACT
11. Intravenous urography. Intravenous urography
2. Retrograde Pyelography2. Retrograde Pyelography
3. Percutaneous Antegrade Urograms3. Percutaneous Antegrade Urograms
4. Cystography/ Voiding Cystograms4. Cystography/ Voiding Cystograms
5. Urethrography5. Urethrography
6. Vasography6. Vasography
7. Angiography7. Angiography
![Page 34: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/34.jpg)
8. Sonography8. Sonography
9. Computed Tomography9. Computed Tomography
10. Magnetic Resonance Imaging10. Magnetic Resonance Imaging
![Page 35: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/35.jpg)
URINARY URINARY OBSTRUCTION AND OBSTRUCTION AND
STASISSTASISClassified accdg.to:Classified accdg.to:
a. cause (congenital or acquired)a. cause (congenital or acquired)
b. duration (acute or chronic)b. duration (acute or chronic)
c. degree (complete or partial)c. degree (complete or partial)
d. level (upper,middle, or lower)d. level (upper,middle, or lower)
![Page 36: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/36.jpg)
EtiologyEtiology
1. Congenital - meatal stenosis,ectopic1. Congenital - meatal stenosis,ectopic
ureters,posterior urethralureters,posterior urethral
valvesvalves
2. Acquired – urethral strictures,BPH,2. Acquired – urethral strictures,BPH,
Prostatic CA,bladder tumor,Prostatic CA,bladder tumor,
ureteral ureteral stones,retroperitonealstones,retroperitoneal
fibrosis,pregnancyfibrosis,pregnancy
![Page 37: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/37.jpg)
Pathogenes and Pathogenes and Pathology:Pathology:
1. Lower Tract (urethral strictures)1. Lower Tract (urethral strictures)
2. Mid-tract (BPH)2. Mid-tract (BPH)
a. trabeculation of the bladder a. trabeculation of the bladder wallwall
b. cellulesb. cellules
c. diverticulac. diverticula
![Page 38: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/38.jpg)
Upper TractUpper Tract
a. uretera. ureter
b. kidneysb. kidneys
![Page 39: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/39.jpg)
Clinical findings:Clinical findings:
A. SymptomsA. Symptoms
1. Lower and mid tract1. Lower and mid tract
2. Upper tract2. Upper tract
B. SignsB. Signs
1. Lower and mid tract1. Lower and mid tract
2. Upper tract2. Upper tract
![Page 40: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/40.jpg)
Laboratory findings:Laboratory findings:
11. Anemia. Anemia
2. Leucocytosis2. Leucocytosis
3. Urinalysis results3. Urinalysis results
4. Blood chemistry ( BUN and Serum 4. Blood chemistry ( BUN and Serum
creatinine)creatinine)
![Page 41: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/41.jpg)
Ancillary proceduresAncillary procedures
1. Xray findings (e.g. Plain film, IVP)1. Xray findings (e.g. Plain film, IVP)
2. Isotope scanning2. Isotope scanning
3. Instrumental examination3. Instrumental examination
4. Interventional uroradiology4. Interventional uroradiology
![Page 42: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/42.jpg)
ComplicationsComplications
1. Infection1. Infection
2. Precipitation of salts - stone 2. Precipitation of salts - stone formationformation
3. Compromise in renal function3. Compromise in renal function
![Page 43: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/43.jpg)
TreatmentTreatment
A. Relief of ObstructionA. Relief of Obstruction
1. Lower and midtract obstruction1. Lower and midtract obstruction
2. Upper tract obstruction2. Upper tract obstruction
B. Eradication of InfectionB. Eradication of Infection
![Page 44: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/44.jpg)
URINARY STONE URINARY STONE DISEASEDISEASE
EtiologyEtiology
1. Crystal component1. Crystal component
2. Matrix component2. Matrix component
![Page 45: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/45.jpg)
Urinary IonsUrinary Ions
1. Calcium 1. Calcium
2. Oxalate 2. Oxalate
3. Phosphate3. Phosphate
4. Uric acid4. Uric acid
5. Sodium5. Sodium
6. Citrate6. Citrate
![Page 46: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/46.jpg)
7. Magnesium7. Magnesium
8. Sulfate8. Sulfate
![Page 47: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/47.jpg)
Stones varietiesStones varieties
A. Calcium calculiA. Calcium calculi
1. Absortive hypercalciuric nephrolithiasis1. Absortive hypercalciuric nephrolithiasis
2. Resorptive hypercalciuric nephrolithiasis2. Resorptive hypercalciuric nephrolithiasis
3. Renal hypercalciuria3. Renal hypercalciuria
4. Hyperuricosuric calcium nephrolithiasis4. Hyperuricosuric calcium nephrolithiasis
5. Hyperoxaluric calcium neprolithiasis5. Hyperoxaluric calcium neprolithiasis
6. Hypercitraturic calcium nephrolithiasis 6. Hypercitraturic calcium nephrolithiasis
![Page 48: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/48.jpg)
B. Noncalcium calculiB. Noncalcium calculi
1. Struvite stones1. Struvite stones
2. Uric acid stones2. Uric acid stones
3. Cystine stones3. Cystine stones
4. Xanthine stones4. Xanthine stones
![Page 49: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/49.jpg)
Symptoms and Signs at Symptoms and Signs at PresentationPresentation
1. Pain1. Pain
2. Hematuria2. Hematuria
3. Infection3. Infection
4. Fever4. Fever
5. Nausea and Vomiting5. Nausea and Vomiting
6. Asymptomatic6. Asymptomatic
![Page 50: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/50.jpg)
Risk factorsRisk factors
1. Crystalluria 1. Crystalluria
2. Socioeconomic factors2. Socioeconomic factors
3. Diet 3. Diet
4. Occupation4. Occupation
5. Climate5. Climate
6. Family History6. Family History
![Page 51: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/51.jpg)
7. Medications7. Medications
e.g. long term use of e.g. long term use of antacids, antacids,
triamterene, carbonic triamterene, carbonic anhydrase anhydrase
inhibitorsinhibitors
![Page 52: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/52.jpg)
Radiologic investigationRadiologic investigation
1. IVP1. IVP
2. Tomography2. Tomography
3. KUB films and sonography3. KUB films and sonography
4. Retrograde Pyelography4. Retrograde Pyelography
5. CT scan5. CT scan
6. MRI6. MRI
7. Nuclear scintigraphy7. Nuclear scintigraphy
![Page 53: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/53.jpg)
InterventionIntervention
11. Observation . Observation
2. Dissolution agents 2. Dissolution agents
3. Relief of obstruction3. Relief of obstruction
4. Extracorporeal Shock Wave 4. Extracorporeal Shock Wave LithotripsyLithotripsy
(ESWL)(ESWL)
5. Ureterospic stone extraction5. Ureterospic stone extraction
6. Percutaneous nephrolithotomy (PCNL)6. Percutaneous nephrolithotomy (PCNL)
![Page 54: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/54.jpg)
7. Open stone surgery7. Open stone surgery
a. Pyelolithotomya. Pyelolithotomy
b. Anatropic nephrolithotomyb. Anatropic nephrolithotomy
![Page 55: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/55.jpg)
PreventionPrevention
1. Metabolic evaluation1. Metabolic evaluation
2. Oral medications2. Oral medications
1. Alkalinizing agents1. Alkalinizing agents
2. Gastrointestinal absorption 2. Gastrointestinal absorption inhibitorinhibitor
3. Phosphate supplementation3. Phosphate supplementation
4. Diuretics4. Diuretics
![Page 56: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/56.jpg)
5. Urease inhibitors5. Urease inhibitors
6. Uric acid lowering medications6. Uric acid lowering medications
![Page 57: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/57.jpg)
UROTHELIAL UROTHELIAL CARCINOMASCARCINOMAS
BLADDER CARCINOMASBLADDER CARCINOMAS
Incidence:Incidence:
Male:female ratio (2.7:1)Male:female ratio (2.7:1)
Average age at diagnosis: 65 Average age at diagnosis: 65
![Page 58: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/58.jpg)
Risk factorsRisk factors
1. Cigarette smoking1. Cigarette smoking
2. Occupational exposures (chemical, 2. Occupational exposures (chemical, dye,dye,
rubber, petroleum, leather, rubber, petroleum, leather, printing)printing)
3. cyclophosphamide3. cyclophosphamide
![Page 59: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/59.jpg)
Types:Types:
1. Transitional Cell carcinomas - 1. Transitional Cell carcinomas - comprise comprise
90% of all bladder cancers90% of all bladder cancers
2. Adenocarcinomas - <2% of all bladder 2. Adenocarcinomas - <2% of all bladder
cancerscancers
3. Squamous cell carcinomas - 5-10%3. Squamous cell carcinomas - 5-10%
4. Undifferentiated CA4. Undifferentiated CA
5.Mixed CA5.Mixed CA
![Page 60: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/60.jpg)
Clinical findingsClinical findings
A. SymptomsA. Symptoms
1. Hematuria- 85-90% of patients with 1. Hematuria- 85-90% of patients with
bladder CAbladder CA
2. Irritability2. Irritability
3. Frequency3. Frequency
4. Dysuria4. Dysuria
5. Advanced disease-bone pain or flank 5. Advanced disease-bone pain or flank painpain
![Page 61: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/61.jpg)
B. SignsB. Signs
1. Mass1. Mass
2. Hepatomegaly2. Hepatomegaly
3. Supraclavicular 3. Supraclavicular lymphadenopathylymphadenopathy
![Page 62: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/62.jpg)
LaboratoriesLaboratories
1.1. Urinalysis Urinalysis
2. Hemogram2. Hemogram
3. Urinary cytology and flow 3. Urinary cytology and flow cytometrycytometry
4. Cell surface antigens4. Cell surface antigens
![Page 63: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/63.jpg)
ImagingImaging
1. Sonography1. Sonography
2. IVP2. IVP
3. CT Scan3. CT Scan
4. MRI4. MRI
![Page 64: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/64.jpg)
TreatmentTreatment
1. Cystourethroscopy and Tumor 1. Cystourethroscopy and Tumor resectionresection
2. Intravesical Chemotherapy2. Intravesical Chemotherapy
a. Mitomycina. Mitomycin
b. Thiotepab. Thiotepa
c. Doxorubicinc. Doxorubicin
d. BCGd. BCG
![Page 65: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/65.jpg)
3.Open surgery3.Open surgery
a. Partial cystectomya. Partial cystectomy
b. Radical cystectomyb. Radical cystectomy
4. Radiotherapy4. Radiotherapy
5. Systemic Chemotherapy (MVAC)5. Systemic Chemotherapy (MVAC)
![Page 66: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/66.jpg)
URETERAL AND RENAL URETERAL AND RENAL PELVIC CANCERSPELVIC CANCERS
Ratio of bladder: Renal pelvic : Ureteral Ratio of bladder: Renal pelvic : Ureteral
cancers – 51:3:1cancers – 51:3:1
Mean age at diagnosis : 65y/oMean age at diagnosis : 65y/o
Male:Female ratio – 2-4:1Male:Female ratio – 2-4:1
Risk of developing bladder CA : 30-50%Risk of developing bladder CA : 30-50%
Risk of developing upper tract CA : 2-4%Risk of developing upper tract CA : 2-4%
Patients with bladder CA have a <2% risk of Patients with bladder CA have a <2% risk of
developing upper tract CA’s developing upper tract CA’s
![Page 67: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/67.jpg)
Etiology/Risk factors:Etiology/Risk factors:
1. Smoking1. Smoking
2. Exposure to industrial dyes or 2. Exposure to industrial dyes or solventssolvents
3. Long history of analgesic intake3. Long history of analgesic intake
4. Balkan nephropathy4. Balkan nephropathy
5. Aspirin, caffeine, and phenacetin5. Aspirin, caffeine, and phenacetin
![Page 68: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/68.jpg)
Pathology:Pathology:
Majority(90-97%) are Transitional Cell Majority(90-97%) are Transitional Cell
CarcinomasCarcinomas
Squamous cell CA account for 10%Squamous cell CA account for 10%
Most are localized at the time of diagnosisMost are localized at the time of diagnosis
Most common metastatic sites: regionalMost common metastatic sites: regional
lymph nodes,bones, and lunglymph nodes,bones, and lung
Benign tumors: fibroepithelial polyp(most Benign tumors: fibroepithelial polyp(most
common),leiomyomas and common),leiomyomas and angiomasangiomas
![Page 69: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/69.jpg)
Most common malignant mesodermal Most common malignant mesodermal
tumor: leiomyosarcomastumor: leiomyosarcomas
![Page 70: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/70.jpg)
Clinical FindingsClinical Findings
Gross hematuria (70-90%)Gross hematuria (70-90%)
Flank pain (8-50%)Flank pain (8-50%)
Irritative voiding symptoms (5-10%)Irritative voiding symptoms (5-10%)
Flank mass (10-20%)Flank mass (10-20%)
Supraclavicular of inguinal Supraclavicular of inguinal lymhadenopathylymhadenopathy
![Page 71: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/71.jpg)
LaboratoryLaboratory
Hematuria ( may be intermittent)Hematuria ( may be intermittent)
Liver function testLiver function test
Pyuria and bacteriuria – patients with Pyuria and bacteriuria – patients with
concomitant concomitant UTIUTI
Barbotage – exfoliated cellsBarbotage – exfoliated cells
Ureteral brush – increases diagnostic Ureteral brush – increases diagnostic
accuracyaccuracy
![Page 72: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/72.jpg)
ImagingImaging
1. IVP1. IVP
2. CT Scan2. CT Scan
3. MRI3. MRI
Endoscopic proceduresEndoscopic procedures
UreteropyeloscopyUreteropyeloscopy
![Page 73: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/73.jpg)
TreatmentTreatment
11. Surgery (nephroureterectomy) : . Surgery (nephroureterectomy) : standardstandard
therapytherapy
2. Chemotherapy (BCG, mitomycin) 2. Chemotherapy (BCG, mitomycin)
3. Radiotherapy : limited role3. Radiotherapy : limited role
![Page 74: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/74.jpg)
GENITAL TUMORSGENITAL TUMORS
Tumors of the TestisTumors of the Testis
A. Germ Cell Tumors ( 90-95% )A. Germ Cell Tumors ( 90-95% )
B. Non-germ cell tumorsB. Non-germ cell tumors
C. Secondary tumorsC. Secondary tumors
![Page 75: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/75.jpg)
Germ Cell TumorsGerm Cell Tumors
Epidemiology and Risk factorsEpidemiology and Risk factors
- 2-3 new cases per 100,000 males- 2-3 new cases per 100,000 males
- 1-2% billateral- 1-2% billateral
- 7-10% develop in men with hx of cryptorchidism- 7-10% develop in men with hx of cryptorchidism
- abdominal testis (risk of malignancy 1 in 20)- abdominal testis (risk of malignancy 1 in 20)
- inguinal testis (risk of malignancy is 1 in 50)- inguinal testis (risk of malignancy is 1 in 50)
- estrogen administration to the mother during- estrogen administration to the mother during
pregnancypregnancy
![Page 76: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/76.jpg)
Two types of germ cell Two types of germ cell tumors:tumors:
A. Seminomatous ( seminoma)A. Seminomatous ( seminoma)
B. Non-seminomatousB. Non-seminomatous
1. Embryonal carcinoma1. Embryonal carcinoma
a. adult typea. adult type
b. yolk sac tumorsb. yolk sac tumors
2. Teratoma2. Teratoma
3. Choriocarcinoma3. Choriocarcinoma
![Page 77: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/77.jpg)
Seminoma (most common overall)Seminoma (most common overall)
- 3 types- 3 types
1. Classic1. Classic
2. Anaplastic2. Anaplastic
3. Spermatocytic3. Spermatocytic
![Page 78: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/78.jpg)
Patterns of spreadPatterns of spread
- typically spreads in a stepwise - typically spreads in a stepwise lymphaticlymphatic
fashion, except choriocarcinomafashion, except choriocarcinoma
- LN’s extend from T1 – L4- LN’s extend from T1 – L4
![Page 79: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/79.jpg)
Primary landing sites:Primary landing sites:
Left testis - paraaortic area at the Left testis - paraaortic area at the level of level of
left renal hilumleft renal hilum
Right testis – interaortocaval area at Right testis – interaortocaval area at the the
level of right renal level of right renal hilumhilum
![Page 80: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/80.jpg)
Clinical FindingsClinical Findings
A. SymptomsA. Symptoms
- painless enlargement- painless enlargement
- acute pain ( 10% )- acute pain ( 10% )
- back pain- back pain
- dyspnea- dyspnea
- cough- cough
- bone pain- bone pain
- asymptomatic ( 10% )- asymptomatic ( 10% )
![Page 81: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/81.jpg)
B. SignsB. Signs
- mass / diffuse enlargement- mass / diffuse enlargement
- examination of the abdomen- examination of the abdomen
- supraclavicular nodes / inguinal - supraclavicular nodes / inguinal nodesnodes
- gynecomastia- gynecomastia
![Page 82: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/82.jpg)
Tumor markers:Tumor markers:
1. AFP1. AFP
2. hCG2. hCG
3. LDH3. LDH
4. PLAP4. PLAP
5. Gamma glutamyl 5. Gamma glutamyl transpeptidasetranspeptidase
![Page 83: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/83.jpg)
Incidence of elevated Incidence of elevated tumor markerstumor markers
hCG(%) AFP(%)hCG(%) AFP(%)
Seminoma 7 0Seminoma 7 0
Teratoma 25 38Teratoma 25 38
Teratocarcinoma 57 64Teratocarcinoma 57 64
Embryonal 60 70Embryonal 60 70
Choriocacinoma 100 0Choriocacinoma 100 0
![Page 84: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/84.jpg)
Laboratories:Laboratories:
Liver function testsLiver function tests
HemogramHemogram
Assessment of renal function – for Assessment of renal function – for chemotherapychemotherapy
ImagingImaging
1. Scrotal ultrasonography1. Scrotal ultrasonography
2. Chest radiographs2. Chest radiographs
3. Abdominal CT scan3. Abdominal CT scan
![Page 85: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/85.jpg)
Differential DxDifferential Dx
1. Epidydimitis/epidimoorchitis – most 1. Epidydimitis/epidimoorchitis – most commoncommon
2. Hydrocele2. Hydrocele
3. Spermatocele3. Spermatocele
4. Hematocele4. Hematocele
5. Granulomatous orchitis5. Granulomatous orchitis
6. Varicocele6. Varicocele
7. Epidermoid cyst 7. Epidermoid cyst
![Page 86: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/86.jpg)
Staging:Staging:
Stage I – confined to the testisStage I – confined to the testis
Stage IIA - <2cm retroperitoneal lymphStage IIA - <2cm retroperitoneal lymph
node involvementnode involvement
Stage IIA - >2cm retroperitoneal lymphStage IIA - >2cm retroperitoneal lymph
node involvementnode involvement
Stage III - supradiaphragmatic nodal Stage III - supradiaphragmatic nodal involveinvolve
ment or visceral involvementment or visceral involvement
![Page 87: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/87.jpg)
TreatmentTreatment
1. Radical Orchiectomy (inguinal approach)1. Radical Orchiectomy (inguinal approach)
Scrotal approach – to be avoidedScrotal approach – to be avoided
SeminomaSeminoma A. Low stage ( I, IIA )A. Low stage ( I, IIA )
- 95% are cured with radical - 95% are cured with radical orchiectomyorchiectomy
and retroperitoneal irradiationand retroperitoneal irradiation
((2500-3000 cGY)((2500-3000 cGY)
![Page 88: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/88.jpg)
Low volume retroperitoneal dse. – Low volume retroperitoneal dse. – 87% 5yr.87% 5yr.
Survival rateSurvival rate
Prophylactic mediastinal irradiation – Prophylactic mediastinal irradiation – no no
longer employedlonger employed
![Page 89: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/89.jpg)
B. High Stage Seminoma ( IIB,III )B. High Stage Seminoma ( IIB,III )
Radical Orchiectomy plus Primary Radical Orchiectomy plus Primary
ChemotherapyChemotherapy
Primary chemotherapy – platinum Primary chemotherapy – platinum basedbased
- PVB- PVB
- VAB- VAB
![Page 90: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/90.jpg)
Nonseminomatous Germ Nonseminomatous Germ Cell Tumors (NSGCT)Cell Tumors (NSGCT)
A. Low Stage NSGCTA. Low Stage NSGCT Radical orchiectomy plus:Radical orchiectomy plus: 1. Retroperitoneal Lymph Node Dissection1. Retroperitoneal Lymph Node Dissection (RPLND)(RPLND) 2. Modified RPLND2. Modified RPLND 3. Surveillance (MSKCC):3. Surveillance (MSKCC): 1. Confined within the tunica albuginea1. Confined within the tunica albuginea 2. Does not demonstrate vascular 2. Does not demonstrate vascular
invasioninvasion 3. Tumor markers normalize after 3. Tumor markers normalize after
orchiectomy orchiectomy
![Page 91: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/91.jpg)
4. Imaging does not show evidence of 4. Imaging does not show evidence of
diseasedisease
5. Reliable patient5. Reliable patient
Surveillance:Surveillance:
Followed monthly for the first two years Followed monthly for the first two years
and bimonthly in the third year.and bimonthly in the third year.
Tumors markers are obtained in each visitTumors markers are obtained in each visit
and imaging studies obtained every 3-4 and imaging studies obtained every 3-4 months. months.
![Page 92: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/92.jpg)
Relapses: majority are within the 8 –10Relapses: majority are within the 8 –10 months.months.
C. High Stage Nonseminomatous C. High Stage Nonseminomatous germ Cell germ Cell
Tumors:Tumors: Radical orchiectomy plus primary Radical orchiectomy plus primary
chemotherapychemotherapy If after chemotherapy, tumor markers If after chemotherapy, tumor markers
normalize and a residual tumor is apparent normalize and a residual tumor is apparent on imaging studies,resection of that mass is on imaging studies,resection of that mass is necessary, because: necessary, because:
![Page 93: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/93.jpg)
a. 20% of the time, it will harbor residual a. 20% of the time, it will harbor residual
cancercancer
b. 40% of the time, it will be teratomab. 40% of the time, it will be teratoma
c. 40% of the time, it will be fibrosisc. 40% of the time, it will be fibrosis
If after chemotherapy, tumor markers do notIf after chemotherapy, tumor markers do not
normalize,normalize,
Salvage chemotherapy is required ( cisplatin,Salvage chemotherapy is required ( cisplatin,
etoposide, bleomycin, efosfamide )etoposide, bleomycin, efosfamide )
![Page 94: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/94.jpg)
Follow up after RPLND or radiotherapy:Follow up after RPLND or radiotherapy: Every 3 months for the first two Every 3 months for the first two
years,years, Every 6 monyhs until 5 years,Every 6 monyhs until 5 years, YearlyYearlyFor each visit,For each visit, PE of the remaining testis, the PE of the remaining testis, the
abdomenabdomen and lymph node areasand lymph node areas AFP, hCG, DH levels; Chest Xray AFP, hCG, DH levels; Chest Xray
![Page 95: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/95.jpg)
Prognosis:Prognosis:
Stage I – 98% 5 year disease-freeStage I – 98% 5 year disease-free
survival survival
Stage II – 95% 5 year disease-Stage II – 95% 5 year disease-free free
survivalsurvival
Stage III- 35-75% 5 year disease-Stage III- 35-75% 5 year disease-free free
survival survival
![Page 96: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/96.jpg)
Non germ cell tumors of Non germ cell tumors of the testisthe testis
11. Leydig cell tumors. Leydig cell tumors
2. Sertoli cell tumors2. Sertoli cell tumors
3. Gonadoblastoma3. Gonadoblastoma
![Page 97: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/97.jpg)
Leydig cell tumorsLeydig cell tumors
- most common non-germ cell tumor - most common non-germ cell tumor of theof the
testistestis
Bimodal distribution: 5-9 year oldBimodal distribution: 5-9 year old
25-35 year old25-35 year old
- unlike germ cell tumors, there is no - unlike germ cell tumors, there is no
association with cryptorchidismassociation with cryptorchidism
![Page 98: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/98.jpg)
Presentation:Presentation:
- prepubertal children - prepubertal children present with present with
virilizationvirilization
- 20-25% of adults with these - 20-25% of adults with these tumors tumors
have gynecomastiahave gynecomastia
- 10% are malignant- 10% are malignant
![Page 99: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/99.jpg)
Laboratory:Laboratory: -elevated serum and urinary ketosteroids-elevated serum and urinary ketosteroids (elevations of 10-30X normal are typical(elevations of 10-30X normal are typical of malignancy)of malignancy) - elevated estrogens- elevated estrogensTreatmentTreatment 1. Radical orchiectomy- initial form of 1. Radical orchiectomy- initial form of treatmenttreatment 2. RPLND2. RPLND
![Page 100: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/100.jpg)
4. Chemotherapy and radiotherapy - not 4. Chemotherapy and radiotherapy - not clearly defined rolesclearly defined roles
2. Sertoli cell tumors2. Sertoli cell tumors - exceedingly rare- exceedingly rare - Bimodal distribution: 1 year old or - Bimodal distribution: 1 year old or
youngeryounger - 10% are malignant- 10% are malignant - virilization in children- virilization in children - gynecomastia (30%) in adults- gynecomastia (30%) in adults
![Page 101: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/101.jpg)
- Radical orchiectomy – initial - Radical orchiectomy – initial treatmenttreatment
- RPLND indicated in malignant - RPLND indicated in malignant tumorstumors
- role of chemotherapy and - role of chemotherapy and radiotherapyradiotherapy
remain unclearremain unclear
![Page 102: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/102.jpg)
3. Gonadoblastomas:3. Gonadoblastomas: - almost exclusively seen if patient with- almost exclusively seen if patient with gonadal dysgenesisgonadal dysgenesis - majority are under 30 y/o- majority are under 30 y/o - 4/5 of patients with - 4/5 of patients with
gonadoblastomas aregonadoblastomas are phenotypic femalesphenotypic females - males typically have cryptorchidism - males typically have cryptorchidism
or or hypospadiashypospadias
![Page 103: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/103.jpg)
- radical orchiectomy – primary treatment ofradical orchiectomy – primary treatment of
choice choice - in the presence of gonadal dysgenesis, ain the presence of gonadal dysgenesis, a
contralateral gonadectomycontralateral gonadectomy
is indicated because the is indicated because the
tumors tends to be tumors tends to be bilateralbilateral
in 50% of casesin 50% of cases
![Page 104: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/104.jpg)
Secondary tumors of the Secondary tumors of the testistestis
1. 1. LymphomaLymphoma- the most common testicular- the most common testicular tumors in a patient over the tumors in a patient over the age of 50.age of 50. - most common - most common
secondarysecondary neoplasm of the testisneoplasm of the testis
![Page 105: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/105.jpg)
Seen in 3 clinical settings:Seen in 3 clinical settings:
a. late manifestation of widespread a. late manifestation of widespread manifistationmanifistation
b. initial manifestation of clinically occult b. initial manifestation of clinically occult diseasedisease
c. primary extranodal diseasec. primary extranodal disease
- painless enlargement- painless enlargement
- generalized constitutional symptoms- generalized constitutional symptoms
- 50% bilaterality- 50% bilaterality
![Page 106: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/106.jpg)
Radical orchiectomy – to confirm the diagnosisRadical orchiectomy – to confirm the diagnosis -treatment is for the systemic disease-treatment is for the systemic disease - prognosis depends on the stage of the disease.- prognosis depends on the stage of the disease.
2. Leukemic infiltration of the testis2. Leukemic infiltration of the testis - the testis is a common site of relapse for - the testis is a common site of relapse for
children children with acute lymphocytic leukemia.with acute lymphocytic leukemia. - 50% bilateral involvement- 50% bilateral involvement - testis biopsy rather than orchiectomy is the - testis biopsy rather than orchiectomy is the
diag-diag- nostic procedure of choice.nostic procedure of choice.
![Page 107: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/107.jpg)
Treatment of choice:Treatment of choice:
1. Testicular irradiation1. Testicular irradiation 2. Adjuvant chemotherapy2. Adjuvant chemotherapy3. Metastatic tumors:3. Metastatic tumors: 1. Prostate – most common primary1. Prostate – most common primary 2. Lung2. Lung 3. GI tract3. GI tract 4. Melanoma4. Melanoma 5. kidney5. kidney
![Page 108: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/108.jpg)
RENAL PARENCHYMAL RENAL PARENCHYMAL NEOPLASMSNEOPLASMS
Benign tumorsBenign tumors
1. Adenomas1. Adenomas – most common benign – most common benign tumor lesionstumor lesions
2. Oncocytoma2. Oncocytoma -high grade oncocytomas may be -high grade oncocytomas may be
intermixed with elements of RCC intermixed with elements of RCC
and can be found as co-existing and can be found as co-existing elements elements
with the same or opposite kidney. with the same or opposite kidney.
![Page 109: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/109.jpg)
3.Angiomyolipoma ( Renal hamatoma)3.Angiomyolipoma ( Renal hamatoma) - found in 45-80% of patients with - found in 45-80% of patients with tuberous sclerosistuberous sclerosis - histologic components: mature fat cell,- histologic components: mature fat cell, smooth muscles, and blood vesselssmooth muscles, and blood vessels - severe bleeding may occur- severe bleeding may occur
4. Others4. Others: leiomyomas, hemagiomas, lipomas,: leiomyomas, hemagiomas, lipomas, juxtaglomerular cell tumorsjuxtaglomerular cell tumors
![Page 110: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/110.jpg)
Renal Cell Carcinoma (Adenocarcinoma Renal Cell Carcinoma (Adenocarcinoma ofof
the Kidney)the Kidney) -account for 35 of adult cancer and-account for 35 of adult cancer and
85% of all primary malignant85% of all primary malignant
renal tumorsrenal tumors
- 5- 5thth to 6 to 6thth decade decade
Other terms: hypernephroma, clear cell Other terms: hypernephroma, clear cell carcinomas, carcinomas,
alveolar carcinomasalveolar carcinomas
![Page 111: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/111.jpg)
Etiology/Risk factorsEtiology/Risk factors
Von Hippel Lindau DiseaseVon Hippel Lindau Disease Horseshoe kidneyHorseshoe kidney Adult polycystic kidney diseaseAdult polycystic kidney disease Acquired renal cystic disease (4-9% of Acquired renal cystic disease (4-9% of patients with ACDK)patients with ACDK) Cigarette smokingCigarette smoking Analgesic abuseAnalgesic abuse Shoe workers, leather tanners, asbestos, Shoe workers, leather tanners, asbestos, petroleum productspetroleum products
![Page 112: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/112.jpg)
PathologyPathology
originates from the proximal renal originates from the proximal renal tubulartubular
epithelium equal frequency in both epithelium equal frequency in both
kidneyskidneys
Types:Types:
1. Clear cell type1. Clear cell type
2. Granular cell type2. Granular cell type
3. Mixed cell type3. Mixed cell type
![Page 113: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/113.jpg)
PathogenesisPathogenesis
vascular tumors that spread either by vascular tumors that spread either by
direct invasion through the capsule into direct invasion through the capsule into
the perinephric fat and adjacent visceral the perinephric fat and adjacent visceral
structures or by direct extension into structures or by direct extension into
the renal vein \the renal vein \
most common site of mets : most common site of mets : lunglung
![Page 114: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/114.jpg)
Clinical FindingsClinical Findings
A.A. Symptoms and SignsSymptoms and Signs Classic triad: gross hematuria, flank Classic triad: gross hematuria, flank
pain,pain, and palpable mass and palpable mass (10 – 15% of patients)(10 – 15% of patients) Hematuria (gross or microscopic) – 60%Hematuria (gross or microscopic) – 60% Pain/abdominal mass – 40%Pain/abdominal mass – 40% Dyspnea/cough/bone pain – Dyspnea/cough/bone pain –
manifestationsmanifestations of metsof mets
![Page 115: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/115.jpg)
B. Paraneoplastic syndromeB. Paraneoplastic syndrome 1. Erythtrocytosis1. Erythtrocytosis 2. Hypercalcemia2. Hypercalcemia 3. Hypertension3. Hypertension 4. Stauffer’s syndrome4. Stauffer’s syndromeLaboratoryLaboratory UrinalysisUrinalysis CBCCBC Blood chemistryBlood chemistry
![Page 116: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/116.jpg)
ImagingImaging
UltrasoundUltrasound Excretory urography Excretory urography CT ScanningCT Scanning MRIMRI Renal angiographyRenal angiography Radionuclide imagingRadionuclide imaging
Fine needle aspirationFine needle aspirationInstrument and Cystologic examination Instrument and Cystologic examination
![Page 117: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/117.jpg)
TreatmentTreatment A. Localized diseaseA. Localized disease Radical nephrectomyRadical nephrectomy
C. Disseminated DiseaseC. Disseminated Disease Adjunctive nephrectomyAdjunctive nephrectomy Paliative nephrectomyPaliative nephrectomy
![Page 118: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/118.jpg)
Chemo / ImmunotherapyChemo / Immunotherapy
Radiation therapyRadiation therapy
Spontaneous RegressionSpontaneous Regression
PrognosisPrognosis
![Page 119: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/119.jpg)
NEUROMUSCULAR NEUROMUSCULAR DYSFUNCTION OF THE DYSFUNCTION OF THE
LOWER URINARY TRACTLOWER URINARY TRACTDisease above the brain stemDisease above the brain stem
1. CVA 1. CVA
2. Dementia2. Dementia
3. Concussion3. Concussion
4. Brain tumors4. Brain tumors
5. Hydrocephalus5. Hydrocephalus
6. Cerebral Palsy6. Cerebral Palsy
![Page 120: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/120.jpg)
7. Parkinson’s Disease7. Parkinson’s Disease
![Page 121: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/121.jpg)
Diseases involving spinal cordDiseases involving spinal cord
1. Multiple sclerosis1. Multiple sclerosis
2. Spinal cord injuries2. Spinal cord injuries
- suprasacal- suprasacal
- sacral- sacral
![Page 122: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/122.jpg)
Diseases distal to the spinal cordDiseases distal to the spinal cord
1. Disc diseases and spinal stenosis1. Disc diseases and spinal stenosis
2. After pelvic surgery2. After pelvic surgery
3. Herpes3. Herpes
4. Diabetis mellitus4. Diabetis mellitus
![Page 123: Urology Lecture](https://reader036.vdocuments.site/reader036/viewer/2022081413/5470bb28b4af9f426b8b5040/html5/thumbnails/123.jpg)
URODYNAMICSURODYNAMICS
(Urodynamic studies, urodynamic (Urodynamic studies, urodynamic testing)testing)
1. Uroflowmetry1. Uroflowmetry
2. Cystometrogram2. Cystometrogram
3. Pressure flow studies3. Pressure flow studies
4. Urethral pressure profilometry4. Urethral pressure profilometry